Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-024831 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 7, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
13,750
Total Value
$485,122.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 4,125 | $22.86 | $94,297.50 | 215,273 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 3,225 | $70.33 | $226,814.25 | 212,048 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 2,075 | $71.98 | $149,358.50 | 209,973 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 200 | $73.26 | $14,652.00 | 209,773 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 4, 2026 | Exercise/Conversion | 4,125 | $0.00 | $0.00 | 131,290 | Direct | โ | View Details |